Showing results (1-10 of 695) with videos related to
Sort By:
Pageof 70
Journal of Hematotherapy|August 1, 1996
Human-mouse xenografts in stem cell researchK Wermann, S Fruehauf, R Haas, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.Journal of Hematotherapy|August 1, 1996
Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hoursS Murea, S Fruehauf, W J Zeller, et al.Stem Cells (Dayton, Ohio)|January 1, 1994
CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursorsS Fruehauf, R Haas, W J Zeller, et al.Bone Marrow Transplantation|August 10, 2000
Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cellsB Schiedlmeier, K Wermann, K Kühlcke, et al.Stem Cells (Dayton, Ohio)|August 26, 1998
Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapyS Fruehauf, M R Veldwijk, A Krämer, et al.Acta Haematologica|August 7, 1999
Comparison of different lymphoma cell purging modalities: An experimental study with K422 lymphoma cellsP Hundsdörfer, S Fruehauf, M Haberkorn, et al.Leukemia|March 10, 2001
Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cellsJ Topaly, W J Zeller, S FruehaufBritish Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.Expert Opinion on Biological Therapy|December 4, 2003
Prospects and RISC score of viral gene therapy for sarcomaS Fruehauf, M R Veldwijk, W J Zeller, et al.Pageof 70